Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?

There are few randomized trials to evaluate the use of PSMA-PET in the planning of post-prostatectomy radiotherapy. There are two unresolved questions 1) should we increase the dose to lesions visible on PSMA-PET 2) can we reduce dose in the case of a negative PSMA-PET. In this review, we summarize...

Descripción completa

Detalles Bibliográficos
Autores principales: Champion, Ambroise, Zwhalen, Daniel Rudolf, Oehler, Christoph, Taussky, Daniel, Kroeze, Stephanie G. C., Burger, Irene A., Benzaquen, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548198/
https://www.ncbi.nlm.nih.gov/pubmed/37799463
http://dx.doi.org/10.3389/fonc.2023.1268309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548198/
https://www.ncbi.nlm.nih.gov/pubmed/37799463
http://dx.doi.org/10.3389/fonc.2023.1268309

Ejemplares similares